XML 78 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION - NON-OPTIONS (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended 30 Months Ended
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Jun. 30, 2021
Dec. 31, 2023
Other stock-based compensation          
Contractual term of awards   10 years      
Minimum          
Other stock-based compensation          
Continuous service period for awards to vest   1 year      
Maximum          
Other stock-based compensation          
Continuous service period for awards to vest   3 years      
Restricted stock          
Non-vested other than stock options, number of shares          
Outstanding at the beginning of the period (in shares)   120,542      
Granted (in shares)   56,710      
Vested (in shares)   (41,139)      
Outstanding at the end of the period (in shares)   136,113 120,542   136,113
Other than stock options, weighted-average grant date fair value          
Non-vested at the beginning of the period (in dollars per share)   $ 116.76      
Granted (in dollars per share)   120.67      
Vested (in dollars per share)   115.24      
Non-vested at the end of the period (in dollars per share)   $ 118.84 $ 116.76   $ 118.84
Restricted stock | Officers and Certain Employees          
Non-vested other than stock options, number of shares          
Granted (in shares)   49,480      
Other stock-based compensation          
Vesting period 3 years 3 years 3 years 3 years  
Holding period of awards as a vesting condition       2 years  
Restricted stock | Non Executive Directors          
Non-vested other than stock options, number of shares          
Granted (in shares)   7,230      
Other stock-based compensation          
Vesting period   1 year      
Vesting (as a percent)   50.00%      
Percentage of shares granted to non-executive directors, vesting one year after date of grant   50.00%     50.00%
Performance stock          
Non-vested other than stock options, number of shares          
Outstanding at the beginning of the period (in shares)   166,441      
Granted (in shares)   82,740      
Exercised (in shares)   (5,847)      
Non-attainment (in shares)   (27,143)      
Outstanding at the end of the period (in shares)   216,191 166,441   216,191
Other than stock options, weighted-average grant date fair value          
Non-vested at the beginning of the period (in dollars per share)   $ 122.05      
Granted (in dollars per share)   139.50      
Exercised (in dollars per share)   82.30      
Non-attainment (in dollars per share)   79.84      
Non-vested at the end of the period (in dollars per share)   $ 135.11 $ 122.05   $ 135.11
Other stock-based compensation          
Earn out basis if no goals are met (as a percent)       0.00%  
Earn out basis if some goals are met (as a percent)       100.00%  
Earn out basis if all goals are met (as a percent)   200.00%   200.00% 200.00%
Gold Equivalent Ounces Shares          
Other stock-based compensation          
Contractual term of awards       5 years  
Total Shareholder Return Shares          
Other stock-based compensation          
Contractual term of awards       3 years 3 years
Continuous service period for awards to vest   3 years   3 years 3 years
Earn out basis if no goals are met (as a percent)   0.00%     0.00%
Earn out basis if some goals are met (as a percent)   100.00%     100.00%
Earn out basis if all goals are met (as a percent)   200.00%     200.00%
Stock Appreciation Rights (SARs) [Member]          
Non-vested other than stock options, number of shares          
Outstanding at the beginning of the period (in shares)   174,906      
Granted (in shares) 0 0 0    
Exercised (in shares) 0 (17,627)      
Outstanding at the end of the period (in shares)   157,279 174,906   157,279
Exercisable at the end of the period (in shares)   157,279     157,279
Other than stock options, weighted-average grant date fair value          
Non-vested at the beginning of the period (in dollars per share)   $ 111.65      
Exercised (in dollars per share)   99.34      
Non-vested at the end of the period (in dollars per share)   113.03 $ 111.65   $ 113.03
Exercisable at the end of the period (in dollars per share)   $ 113.03     $ 113.03
Other than stock options, weighted-average remaining contractual life (in years)          
Outstanding at the end of the period   5 years 2 months 12 days      
Exercisable at the end of the period   5 years 2 months 12 days      
Aggregate Intrinsic Value          
Intrinsic value on outstanding shares   $ 2,526     $ 2,526
Intrinsic value on exercisable shares   2,526     $ 2,526
Other stock-based compensation          
Total intrinsic value   $ 700 $ 200 $ 100